DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

Merck & Co., Inc. (NYSE: MRK)



company name or ticker
Company Photos
(Click to zoom)

As Ebola spreads, drug stocks surge

Ebola drug stocks surge as virus spreads to U.S.

Johnson & Johnson Is The Most Attractive Mega-Cap Pharma Stock For Income Investors

Big News for These 5 Stocks From ESMO

But smaller biotechs Clovis Oncology and Exelixis also benefit from the big boys' data.

The ominous volatility burst and a trend to consider when picking those shorts

Bristol-Myers' Opdivo Under Review in US, EU for Cancer Treatment - Analyst Blog

Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog

Indian Prime Minister courts U.S. CEOs

Why Endocyte, Inc. Stock Briefly Spiked Higher

Endocyte stock was briefly among today's top gainers after the company released an encouraging interim update on experimental drug vintafolide as a possible non-small cell lung cancer treatment.

Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader

Copycat technology is the next big thing